UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival

Blood, 2011-06, Vol.117 (25), p.6786-6792

2011

Volltextzugriff (PDF)

Adding a treatment arm to an ongoing clinical trial: a review of methodology and practice

Trials, 2015-04, Vol.16 (1), p.179-179, Article 179

2015

Volltextzugriff (PDF)

A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia

British journal of haematology, 2011-03, Vol.152 (5), p.570-578

2011

Volltextzugriff (PDF)

Measurement of saliva tacrolimus levels in pediatric renal transplant recipients

Pediatric nephrology (Berlin, West), 2011, Vol.26 (1), p.133-138

2011

Volltextzugriff (PDF)

Experiences in the design and implementation of phase II trials in CLL

Trials, 2011-12, Vol.12 (S1), p.A92-A92, Article A92

2011

Volltextzugriff (PDF)

Long Term Treatment with Eculizumab In Paroxysmal Nocturnal Hemoglobinuria (PNH): Sustained Efficacy and Improved Survival

Blood, 2010-11, Vol.116 (21), p.639-639

2010

Volltextzugriff (PDF)

Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway

Nature medicine, 2012-01, Vol.18 (1), p.159-165

2012

Volltextzugriff (PDF)

Community-Based HIV Testing for Urban Youth in Western Kenya

AIDS and behavior, 2022-03, Vol.26 (3), p.814-821

2022

Volltextzugriff (PDF)

Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma

Clinical cancer research, 2009-12, Vol.15 (24), p.7582-7592

2009

Volltextzugriff (PDF)

Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features

Nature genetics, 2022-11, Vol.54 (11), p.1675-1689

2022

Volltextzugriff (PDF)

Congenital polyvalvular disease expands the cardiac phenotype of the RASopathies

American journal of medical genetics. Part A, 2021-05, Vol.185 (5), p.1486-1493

2021

Volltextzugriff (PDF)

Rituximab Plus Chlorambucil As First-Line Treatment for Chronic Lymphocytic Leukemia: Final Analysis of an Open-Label Phase II Study

Journal of clinical oncology, 2014-04, Vol.32 (12), p.1236-1241

2014

Volltextzugriff (PDF)

HIV Infection Among Adolescents Residing in Urban Informal Settlements of Kenya

AIDS education and prevention, 2023-06, Vol.35 (3), p.225-234

2023

Volltextzugriff (PDF)

Implementation of a Community-Based Hybrid HIV Testing Services Program as a Strategy to Saturate Testing Coverage in Western Kenya

Journal of acquired immune deficiency syndromes (1999), 2019-12, Vol.82 (4), p.362-367

2019

Volltextzugriff (PDF)

Genetic and epigenetic analysis of von hippel-lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer

Cancer research (Chicago, Ill.), 2006-02, Vol.66 (4), p.2000-2011

2006

Volltextzugriff (PDF)

A Multi-Center Dose-Finding Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Fimepinostat (CUDC-907) in Combination with Venetoclax in Patients with Relapsed/Refractory (R/R) Lymphoma

Blood, 2019-11, Vol.134 (Supplement_1), p.4104-4104

2019

Volltextzugriff (PDF)

Obinutuzumab As Consolidation after Chemo-Immunotherapy Is Highly Effective in Achieving MRD Clearance from Bone Marrow and Peripheral Blood- Initial Results of UK NCRI Phase II/III Galactic Trial

Blood, 2017-12, Vol.130, p.3013-3013

2017

Volltextzugriff (PDF)

Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation

Haematologica (Roma), 2010-10, Vol.95 (10), p.1705-1712

2010

Volltextzugriff (PDF)

Community-based HIV testing services in an urban setting in western Kenya: a programme implementation study

The lancet HIV, 2021-01, Vol.8 (1), p.e16-e23

2021

Volltextzugriff (PDF)

Community-Based HIV Testing Services in an Urban Setting in Western Kenya: a program implementation

The lancet HIV, 2020-11, Vol.8 (1), p.e16-e23

2020

Volltextzugriff (PDF)

Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia

Haematologica (Roma), 2008-08, Vol.93 (8), p.1247

2008

Volltextzugriff (PDF)

Rituximab Plus Chlorambucil In Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukemia (CLL): Final Response Analysis of An Open-Label Phase II Study

Blood, 2010-11, Vol.116 (21), p.697-697

2010

Volltextzugriff (PDF)

An Open-Label Phase II Study to Investigate the Safety and Efficacy of Rituximab Plus Chlorambucil in Previously Untreated Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukaemia (CLL)

Blood, 2009-11, Vol.114 (22), p.3428-3428

2009

Volltextzugriff (PDF)

NCRI CLL201 Trial: A Randomized Phase II Trial of Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) with or without Rituximab in Previously Treated CLL

Blood, 2007-11, Vol.110 (11), p.752-752

2007

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Humans
(16)
Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Female
(11)
Male
(11)
Adult
(8)
Adolescent
(7)
Middle Aged
(7)
Aged
(6)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Hematology
(5)
Young Adult
(5)
Hematologic And Hematopoietic Diseases
(4)
Hiv
(4)
Infectious Diseases
(4)
Adolescents
(3)
Aged, 80 And Over
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Child
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage

Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival

Adding a treatment arm to an ongoing clinical trial: a review of methodology and practice

A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia

Measurement of saliva tacrolimus levels in pediatric renal transplant recipients

Experiences in the design and implementation of phase II trials in CLL

Long Term Treatment with Eculizumab In Paroxysmal Nocturnal Hemoglobinuria (PNH): Sustained Efficacy and Improved Survival

Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway

Community-Based HIV Testing for Urban Youth in Western Kenya

Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma

Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features

Congenital polyvalvular disease expands the cardiac phenotype of the RASopathies

Rituximab Plus Chlorambucil As First-Line Treatment for Chronic Lymphocytic Leukemia: Final Analysis of an Open-Label Phase II Study

HIV Infection Among Adolescents Residing in Urban Informal Settlements of Kenya

Implementation of a Community-Based Hybrid HIV Testing Services Program as a Strategy to Saturate Testing Coverage in Western Kenya

Genetic and epigenetic analysis of von hippel-lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer

A Multi-Center Dose-Finding Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Fimepinostat (CUDC-907) in Combination with Venetoclax in Patients with Relapsed/Refractory (R/R) Lymphoma

Obinutuzumab As Consolidation after Chemo-Immunotherapy Is Highly Effective in Achieving MRD Clearance from Bone Marrow and Peripheral Blood- Initial Results of UK NCRI Phase II/III Galactic Trial

Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation

Community-based HIV testing services in an urban setting in western Kenya: a programme implementation study

Community-Based HIV Testing Services in an Urban Setting in Western Kenya: a program implementation

Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia

Rituximab Plus Chlorambucil In Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukemia (CLL): Final Response Analysis of An Open-Label Phase II Study

An Open-Label Phase II Study to Investigate the Safety and Efficacy of Rituximab Plus Chlorambucil in Previously Untreated Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukaemia (CLL)

NCRI CLL201 Trial: A Randomized Phase II Trial of Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) with or without Rituximab in Previously Treated CLL

Suchergebnisse filtern